Antibiotic susceptibility of isolates of Bacillus anthracis , a bacterial pathogen with the potential to be used in biowarfare
Clinical Microbiology and Infection, ISSN: 1198-743X, Vol: 9, Issue: 9, Page: 984-986
2003
- 16Citations
- 17Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations16
- Citation Indexes13
- 13
- CrossRef10
- Policy Citations3
- Policy Citation3
- Captures17
- Readers17
- 17
Article Description
Bacillus anthracis is a bacterial species that could be used in a bioterrorist attack. We tested a collection of isolates with a range of relevant antimicrobial compounds. All isolates tested were susceptible to ciprofloxacin and doxycycline. Penicillin and amoxicillin, with or without clavulanate, showed in vitro activity against all B. anthracis isolates. Ceftriaxone demonstrated lower-level in vitro activity compared to penicillin-related compounds against B. anthracis. In vitro data from this study are in keeping with available guidelines.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1198743X14630536; http://dx.doi.org/10.1046/j.1469-0691.2003.00775.x; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0141955076&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/14616693; https://linkinghub.elsevier.com/retrieve/pii/S1198743X14630536
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know